Advertisement
U.S. markets open in 2 hours 35 minutes

Sanofi (SAN.PA)

Paris - Paris Delayed Price. Currency in EUR
87.45-0.55 (-0.63%)
As of 11:40AM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close88.00
Open88.19
Bid0.00 x 0
Ask0.00 x 0
Day's Range87.22 - 88.19
52 Week Range80.60 - 105.18
Volume148,824
Avg. Volume1,299,813
Market Cap109.405B
Beta (5Y Monthly)0.44
PE Ratio (TTM)20.34
EPS (TTM)4.30
Earnings DateApr 25, 2024
Forward Dividend & Yield3.76 (4.27%)
Ex-Dividend DateMay 13, 2024
1y Target Est103.30
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SAN.PA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Sanofi: Information concerning the total number of voting rights and shares - February 2024

      Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,599,938 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi

    • Bloomberg

      PE Firms Eye €7.5 Billion Buyout Financing for Sanofi Unit

      (Bloomberg) -- Potential bidders for Sanofi’s consumer health division are mulling debt packages of about €7.5 billion ($8.16 billion), according to people familiar with the matter, which would make it one of the biggest leveraged buyout financings in recent years.Most Read from BloombergApple Without AI Looks More Like Coca-Cola Than High-Growth TechUS Probing Indian Billionaire Gautam Adani and His Group Over Potential BriberyWhat Does the UAE Get for Its $35 Billion Investment in Egypt?Want t

    • Insider Monkey

      12 Most Profitable Biotech Stocks To Invest In

      In this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology industry and the latest trends, then you can take a look at the 5 Most Profitable Biotech Stocks To Invest In. Biotechnology is the riskiest and […]